Dr. Vince Videos

  1. Accelerating Clinical And Drug Development Timelines With AI 5/8/2026

    This presentation brings together perspectives from across the industry to explore how AI is being applied today to improve clinical project management and unlock new opportunities in drug discovery.

     

  2. Medical Monitoring Oversight And Real-Time Data In Clinical Trials 5/8/2026

    Explore how real-time access to safety data is changing medical monitoring, with insights into continuous analysis, remote data visibility, and what these shifts mean for protecting patients.

  3. In-House CAP And CLIA-Compliant Clinical Laboratory 5/8/2026

    Comprehensive, validated laboratory testing paired with advanced instrumentation and seamless EDC integration helps streamline clinical trials without downtime or data gaps.

  4. Human Abuse Potential: Selecting A Positive Control 5/8/2026

    Choosing an effective positive control in HAP studies is critical but not always straightforward. Learn how to justify comparator and dose selection.

  5. Human Abuse Potential: CSS Interactions 5/8/2026

    Learn how, by embedding FDA engagement into the development process, sponsors can strengthen their abuse potential assessment and support smoother regulatory review.

  6. Neuroscience Showcase: From Chance Discovery To Molecular Biology 5/8/2026

    From chance discoveries to targeted molecular therapies, this presentation examines how advances in neurobiology, genetics, and circuit-based understanding are transforming drug development.

  7. Pharmacy Considerations For Early Phase Trials 5/8/2026

    This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.

  8. Definitive QT Evaluation - Clinical And Operational Considerations 5/8/2026

    QT strategy decisions affect timelines, cost, and regulatory outcomes. This presentation examines when early QT data can support a waiver, how guidance updates influence study design, and more.

  9. Human Abuse Potential: Subjective Ratings 5/5/2026

    Accurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.

  10. Human Abuse Potential: Participant Safety 5/5/2026

    Explore how clinical staffing, monitoring equipment, and structured safety oversight support the safe conduct of Human Abuse Potential studies, including approaches to adverse event management.